IDENTIFYING NOVEL HEPATOCELLULAR CARCINOMA ONCOGENES IN NASH AND NAFLD PUBLIC DATA SETS

被引:0
|
作者
Almasry, Mazen [1 ]
Aljabban, Jihad [2 ]
Panahiazar, Maryam [3 ]
机构
[1] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2054- A
引用
收藏
页码:S812 / S813
页数:2
相关论文
共 50 条
  • [1] NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden
    Georgescu, Doina
    Lighezan, Daniel Florin
    Rosca, Ciprian Ilie
    Nistor, Daciana
    Ancusa, Oana Elena
    Suceava, Ioana
    Iancu, Mihaela Adela
    Kundnani, Nilima Rajpal
    [J]. LIFE-BASEL, 2024, 14 (01):
  • [2] Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
    Vachher, Meenakshi
    Bansal, Savita
    Kumar, Bhupender
    Yadav, Sandeep
    Arora, Taruna
    Wali, Nalini Moza
    Burman, Archana
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (10) : 1553 - 1584
  • [3] Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
    Wang, Fang
    Breslin, S. J. Peter
    Qiu, Wei
    [J]. LIVER RESEARCH, 2021, 5 (04) : 195 - 203
  • [4] Identification of Novel Oncogenes and Tumor Suppressors in Hepatocellular Carcinoma
    Imbeaud, Sandrine
    Ladeiro, Yannick
    Zucman-Rossi, Jessica
    [J]. SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 75 - 86
  • [5] Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
    Elena Piccinin
    Gaetano Villani
    Antonio Moschetta
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 160 - 174
  • [6] Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
    Piccinin, Elena
    Villani, Gaetano
    Moschetta, Antonio
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (03) : 160 - 174
  • [7] The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
    Cervello, Melchiorre
    Augello, Giuseppa
    Cocco, Lucio
    Ratti, Stefano
    Follo, Matilde Y.
    Martelli, Alberto M.
    Cusimano, Antonella
    Montalto, Giuseppe
    McCubrey, James A.
    [J]. ADVANCES IN BIOLOGICAL REGULATION, 2024, 92
  • [8] A Novel Prognostic Algorithm for Patients with NAFLD-related Hepatocellular Carcinoma: A Nationwide Data-mining Analysis by Japan Study Group of NAFLD
    Kawaguchi, Takumi
    Tokushige, Katsutoshi
    Hyogo, Hideyuki
    Aikata, Hiroshi
    Nakajima, Tomoaki
    Ono, Masafumi
    Kawanaka, Miwa
    Sawada, Koji
    Imajo, Kento
    Honda, Koichi
    Takahashi, Hirokazu
    Mori, Kohjiroh
    Tanaka, Saiyu
    Seko, Yuya
    Nozaki, Yuichi
    Kamada, Yoshihiro
    Fujii, Hideki
    Kawaguchi, Atsushi
    Takehara, Tetsuo
    Yanase, Mikio
    Sumida, Yoshio
    Eguchi, Yuichiro
    Seike, Masataka
    Yoneda, Masato
    Suzuki, Yasuaki
    Saibara, Toshiji
    Karino, Yoshiyasu
    Chayama, Kazuaki
    Hashimoto, Etsuko
    George, Jacob
    Torimura, Takuji
    [J]. HEPATOLOGY, 2017, 66 : 763A - 763A
  • [9] Identifying Module Biomarkers of Hepatocellular Carcinoma from Gene Expression Data
    Shen, Chen
    Liu, Zhi-Ping
    [J]. 2017 CHINESE AUTOMATION CONGRESS (CAC), 2017, : 5404 - 5407
  • [10] Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
    Chaudhary, Surendra Pal
    Reyes, Stephanie
    Chase, Matthew L.
    Govindan, Aparna
    Zhao, Lei
    Luther, Jay
    Bhan, Irun
    Bethea, Emily
    Franses, Joseph W.
    Paige Walsh, Elizabeth
    Anne Dageford, Leigh
    Kimura, Shoko
    Elias, Nahel
    Yeh, Heidi
    Markman, James
    Bozorgzadeh, Adel
    Tanabe, Kenneth
    Ferrone, Cristina
    Zhu, Andrew X.
    Andersson, Karin
    Thiim, Michael
    Antonio Catalano, Onofrio
    Kambadakone, Avinash
    Vagefi, Parsia A.
    Qadan, Motaz
    Pratt, Daniel
    Hashemi, Nikroo
    Corey, Kathleen E.
    Misdraji, Joseph
    Goyal, Lipika
    Clark, Jeffrey W.
    [J]. ONCOLOGIST, 2023, : 341 - 350